[Important points in selecting the first choice and combinations of various hypertensive agents].
Takeda
T
T
Kanayama
Y
Y
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage; D000959:Antihypertensive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001581:Benzothiadiazines; D002121:Calcium Channel Blockers / Q000008:administration & dosage; D004232:Diuretics; D004359:Drug Therapy, Combination; D006801:Humans; D049993:Sodium Chloride Symporter Inhibitors / Q000008:administration & dosage
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D002121:Calcium Channel Blockers; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors